Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$0.34 - $0.48 $136,261 - $192,369
400,769 Added 42.11%
1,352,570 $486,000
Q1 2023

May 15, 2023

SELL
$0.39 - $0.65 $585,000 - $975,000
-1,500,000 Reduced 61.18%
951,801 $380,000
Q4 2022

Feb 14, 2023

BUY
$0.44 - $131.17 $162,800 - $48.5 Million
370,000 Added 17.77%
2,451,801 $1.57 Million
Q1 2022

May 12, 2022

BUY
$0.92 - $1.94 $1.92 Million - $4.04 Million
2,081,801 New
2,081,801 $2.63 Million

Others Institutions Holding VCNX

About VACCINEX, INC.


  • Ticker VCNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,664,100
  • Market Cap $149M
  • Description
  • Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...
More about VCNX
Track This Portfolio

Track Aigh Capital Management LLC Portfolio

Follow Aigh Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aigh Capital Management LLC with notifications on news.